Team‎ > ‎

Science and Technology

JS

Justin R. Savage, Ph.D.
is Director of Operations for GlycoMira Therapeutics, Inc. and has been with the Company since 2009.  Dr. Savage has over 10 years of experience in proteomics and drug development. 
    Dr. Savage received his B.A. degree in chemistry from Southern Utah University and his Ph.D. in Biochemistry from Brigham Young University.

JZ2

Jianxing Zhang, MBA, Ph.D.
is a Senior Research Scientist at GlycoMira Therapeutics and he is developing SAGEs.
    Dr. Zhang received his Ph.D in organic chemistry from the Chinese Academy of Sciences.  He received his MBA from Baylor University along with postdoctoral research training at Baylor University, University of Nebraska Medical Center and University of Utah. Dr. Zhang received Basic Research Award from American Academy of Pediatrics for his outstanding paper (Urology Annual Meeting in 2010).


wy

Won Yong Lee, D.V.M., M.S., Ph.D.
is our Research Scientist and he is leading drug development.  Dr. Lee He has extensive experiences in drug development that he has built during his career in South Korea. In addition, Dr. Lee is an expert in molecular biophysics that greatly benefits GlycoMira's scientific mission.
    Dr. Lee received his Ph.D. in molecular neuroscience from the Mayo Clinic, his D.V.M. and Master's in toxicology from Konkuk University (Seoul, Korea). He was a postdoctoral fellow in NIH Developmental Biology Training Grant and he also received postdoctoral fellowship from American Cancer Society.